Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders

Thibaut Burg; Laura Tzeplaeff; Raphaelle Cassel; Paul Lingor

doi:10.3389/fnins.2025.1582539

Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders

Thibaut Burg
, Laura Tzeplaeff
, Raphaelle Cassel
, Paul Lingor

Department of Neurology

University of Leuven
VIB Center for Inflammation Research
Technical University of Munich
Universite de Strasbourg
German Center for Neurodegenerative Diseases (DZNE)
Munich Cluster for Systems Neurology (SyNergy)

Research output: Contribution to journal › Editorial

Original language	English
Article number	1582539
Journal	Frontiers in Neuroscience
Volume	19
DOIs	https://doi.org/10.3389/fnins.2025.1582539
State	Published - 2025

Keywords

Amyotrophic lateral sclerosis (ALS)
biomarker
clinical research
motor neuron
neurodegeneration
therapy

Access to Document

10.3389/fnins.2025.1582539

Cite this

@article{dd6891cb75a0429684c35bb2e6154298,

title = "Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders",

keywords = "Amyotrophic lateral sclerosis (ALS), biomarker, clinical research, motor neuron, neurodegeneration, therapy",

author = "Thibaut Burg and Laura Tzeplaeff and Raphaelle Cassel and Paul Lingor",

year = "2025",

doi = "10.3389/fnins.2025.1582539",

language = "English",

volume = "19",

journal = "Frontiers in Neuroscience",

issn = "1662-4548",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial

T2 - Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders

AU - Burg, Thibaut

AU - Tzeplaeff, Laura

AU - Cassel, Raphaelle

AU - Lingor, Paul

PY - 2025

Y1 - 2025

KW - Amyotrophic lateral sclerosis (ALS)

KW - biomarker

KW - clinical research

KW - motor neuron

KW - neurodegeneration

KW - therapy

UR - https://www.scopus.com/pages/publications/105001518814

U2 - 10.3389/fnins.2025.1582539

DO - 10.3389/fnins.2025.1582539

M3 - Editorial

AN - SCOPUS:105001518814

SN - 1662-4548

VL - 19

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

M1 - 1582539

ER -

Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders

Keywords

Access to Document

Other files and links

Cite this